Skip to main content
JHS Svendgaard Laboratories Ltd. logo

JHS Svendgaard Laboratories Ltd. — Investor Relations & Filings

Ticker · JHS ISIN · INE544H01014 LEI · 335800NYNAOOMRTTWW75 BSE.NS Manufacturing
Open in API
Filings indexed 678 across all filing types
Latest filing 2023-09-30 Regulatory Filings
Country IN India
Listing BSE.NS JHS

About JHS Svendgaard Laboratories Ltd.

https://www.svendgaard.com/

JHS Svendgaard Laboratories Ltd. is a specialized manufacturer of oral care products, operating primarily through contract manufacturing and private labeling arrangements. The company provides end-to-end solutions for oral hygiene, including the production of toothbrushes, toothpastes, mouthwashes, and specialized dental care items. It maintains large-scale manufacturing facilities equipped to handle high-volume production for global and domestic FMCG brands. In addition to its business-to-business operations, the company manages its own consumer brand, Aquawhite, which focuses on innovative oral care solutions for various age groups, including a significant range of licensed character-based products for children. The organization emphasizes quality control and technical expertise in oral health product development, catering to diverse market segments through a robust supply chain and distribution network.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the closure of the trading window due to upcoming financial results announcement. It references the quarter and half year ended September 30, 2023, but does not contain any financial data or results itself. It is an announcement related to compliance with insider trading regulations and timing of financial results disclosure. The document length is only 1436 characters, indicating it is a brief notice rather than a full report. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as it is a general regulatory announcement related to trading restrictions and compliance.
2023-09-30 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a detailed summary of the proceedings of the 19th Annual General Meeting (AGM) of JHS Svendgaard Laboratories Limited held on September 28, 2023. It includes information about the meeting's conduct, attendees, agenda items, voting procedures, and resolutions passed. The document references the AGM explicitly multiple times and provides a comprehensive account of the meeting rather than just announcing the meeting or voting results. It does not contain financial statements or detailed financial performance data, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a Declaration of Voting Results (DVA) because it summarizes the meeting proceedings rather than just the voting outcomes. Therefore, the document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including summaries of proceedings.
2023-09-28 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a response letter from the company to a query from the stock exchange regarding clarification on financial results. It references a specific board meeting and the signing of financial results for the quarter ended June 30, 2023, but does not contain the financial results themselves. The document is short (1923 characters) and serves as a regulatory communication clarifying procedural details rather than presenting financial data or a report. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and clarifications that do not constitute full reports or filings.
2023-09-25 English
Outcome of Board Meeting
M&A Activity Classification · 100% confidence The document is a detailed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) regarding the approval of a Scheme of Arrangement for Amalgamation between JHS Svendgaard Laboratories Limited (Transferor Company) and Vedic Cosmeceuticals Private Limited (Transferee Company). It includes information about the board meeting outcome, valuation report, fairness opinion, shareholding patterns pre- and post-merger, rationale for the merger, and other details related to the merger process. The document is not a full financial report but an official announcement of a corporate restructuring transaction. It does not contain financial statements or earnings data but focuses on the merger approval and related disclosures. This fits the category of M&A Activity (TAR) as it relates to merger proposals and takeover bids disclosures.
2023-09-22 English
Updates
Board/Management Information Classification · 95% confidence The document is a brief notification addressed to stock exchanges regarding the expiration of the tenure of an Independent Director, Mrs. Rohina Sanjay Sangtani. It references compliance with SEBI Listing Regulations and provides an update on board membership status. There are no financial statements, audit information, or detailed management discussion. The content is about a change in the company's board of directors, specifically the end of a director's term. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and does not indicate it is a report or announcement of a report publication, so it is not RPA or RNS. Confidence is high due to clear mention of director tenure expiration and no other competing document types.
2023-09-16 English
Allotment of Securities
Share Issue/Capital Change Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the allotment of equity shares pursuant to a Composite Scheme of Arrangement involving multiple companies. It details the number of shares allotted, the share exchange ratio, and the resulting increase in the company's paid-up share capital. The document references compliance with SEBI Listing Regulations and provides specific share capital figures and dates. The content is an announcement of a capital change (share allotment) rather than a full financial report or detailed analysis. The document length is relatively short (2428 characters) and it does not contain financial statements or comprehensive financial data. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2023-09-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.